Theratechnologies inc.

Theratechnologies inc.

March 24, 2008 12:24 ET

Theratechnologies: Annual General Meeting of Shareholders

MONTREAL, CANADA--(Marketwire - March 24, 2008) - Mr. Paul Pommier, Chairman of the Board of Theratechnologies (TSX:TH) and Mr. Yves Rosconi, President and Chief Executive Officer, invite shareholders to Theratechnologies' Annual General Meeting that will be held on Wednesday, March 26, 2008, at 10:00 a.m., at the Fairmont Queen Elizabeth Hotel, 900 Rene Levesque Blvd West, in Montreal.

What: Theratechnologies' Annual General Meeting of Shareholders

When: Wednesday, March 26, 2008 at 10:00 a.m.

Where: Fairmont Queen Elizabeth Hotel
900 Rene Levesque Blvd West, Montreal
Marquette Room

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in financially attractive specialty markets. Its most advanced program is tesamorelin, now in a confirmatory Phase 3 clinical trial for a serious metabolic disorder known as HIV-associated lipodystrophy. The Company also has other projects at earlier stages of development.

Contact Information